Skip to main content

Contraceptive Nuvaring Linked to Blood Clots and Stroke

Published November 12, 2012 by

Contraceptive Nuvaring Linked to Blood Clots and StrokeNuvaring is a contraceptive device manufactured by Organon. It was approved by the U.S. Food and Drug Administration (FDA) in 2001. Organon developed and manufactured Nuvaring on the premise of introducing a new form of birth control, one that would supposedly be easier for women to use.

However, it soon became apparent after the release of Nuvaring that there were serious issues with the contraceptive device. Questions began to arise as to the verity of Organon’s marketing campaign promoting Nuvaring, especially regarding third-generation hormones and Nuvaring’s unique hormonal release method.

As the Nuvaring is a contraceptive device used as a vaginal insert, the release of hormones into a woman’s body occurs differently than through oral contraceptives, such as birth control pills. Due to the placement of the Nuvaring inside of a woman’s body, the hormones are released directly into the bloodstream.

With oral contraceptives, hormonal release occurs primarily in the digestive tract. It is thought that the direct release of hormones into the bloodstream has been the cause of deadly blood clots in women who have used Nuvaring.

According to a CBS News report released in the fall of 2012, incidents of women suffering from Nuvaring-related blood clots, strokes, pulmonary embolisms, and deep vein thrombosis (DVT) have surpassed 1,000 cases reported to the FDA. The link between Nuvaring and blood clots leading to strokes or death are concurred through a study published by the British Medical Journal in May 2012, which demonstrated a correlation between the use of Nuvarings, and other vaginally inserted, ring-shaped contraceptives, and a 90% increased risk of blood clot development. In June 2012, the New England Journal of Medicine published a study with similar findings.

Trials for Nuvaring lawsuits are set to start on May 6, 2013, according to U.S. Federal District Judge Rodney W. Sippel. A federal Multi-District Litigation (MDL) court has been established in Missouri to hear the Nuvaring lawsuits.

If you have suffered from blood clots, stroke, pulmonary embolism, or DVT as a result of using a Nuvaring, you may be entitled to receive compensation for your undue suffering. Our attorneys at Carey Danis & Lowe are dedicated to assisting clients through providing them with expert legal advice regarding pharmaceutical product liability litigation.

To file a Nuvaring lawsuit, contact an experienced Nuvaring lawyer at Carey Danis & Lowe today.